Literature DB >> 17329407

Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma.

Rajeev Vibhakar1, Greg Foltz, Jae-Geun Yoon, Lorie Field, Hwahyung Lee, Gi-Yung Ryu, Jessica Pierson, Beverly Davidson, Anup Madan.   

Abstract

Medulloblastoma is a heterogeneous pediatric brain tumor with significant therapy-related morbidity, its five-year survival rates ranging from 30% to 70%. Improvement in diagnosis and therapy requires better understanding of medulloblastoma pathology. We used whole-genome microarray analysis to identify putative tumor suppressor genes silenced by epigenetic mechanisms in medulloblastoma. This analysis yielded 714 up-regulated genes in immortalized medulloblastoma cell line D283 on treatment with histone deacetylase (HDAC) inhibitor trichostatin A (TSA). Dickkopf-1 (DKK1), a Wnt antagonist, was found to be up-regulated on HDAC inhibition. We examined DKK1 expression in primary medulloblastoma cells and patient samples by reverse transcriptase PCR and found it to be significantly down-regulated relative to normal cerebellum. Transfection of a DKK1 gene construct into D283 cell lines suppressed medulloblastoma tumor growth in colony focus assays by 60% (P < 0.001). In addition, adenoviral vector-mediated expression of DKK1 in medulloblastoma cells increased apoptosis fourfold (P < 0.001). These data reveal that inappropriate histone modifications might deregulate DKK1 expression in medulloblastoma tumorigenesis and block its tumor-suppressive activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329407      PMCID: PMC1871668          DOI: 10.1215/15228517-2006-038

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  36 in total

1.  A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.

Authors:  Hiromu Suzuki; Edward Gabrielson; Wei Chen; Ramaswamy Anbazhagan; Manon van Engeland; Matty P Weijenberg; James G Herman; Stephen B Baylin
Journal:  Nat Genet       Date:  2002-05-06       Impact factor: 38.330

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  An epigenetic approach for finding tumor suppressors.

Authors:  Peter A Jones
Journal:  Cell Cycle       Date:  2003 Jan-Feb       Impact factor: 4.534

4.  Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.

Authors:  Jiang Shou; Francis Ali-Osman; Asha S Multani; Sen Pathak; Paolo Fedi; Kalkunte S Srivenugopal
Journal:  Oncogene       Date:  2002-01-31       Impact factor: 9.867

Review 5.  Medulloblastoma: present concepts of stratification into risk groups.

Authors:  Roger J Packer; Brian R Rood; Tobey J MacDonald
Journal:  Pediatr Neurosurg       Date:  2003-07       Impact factor: 1.162

6.  BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.

Authors:  Andrew R Hallahan; Joel I Pritchard; Roshantha A S Chandraratna; Richard G Ellenbogen; J Russel Geyer; Ryan P Overland; Andrew D Strand; Stephen J Tapscott; James M Olson
Journal:  Nat Med       Date:  2003-07-20       Impact factor: 53.440

7.  Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

Authors:  Kurtis E Bachman; Ben Ho Park; Ina Rhee; Harith Rajagopalan; James G Herman; Stephen B Baylin; Kenneth W Kinzler; Bert Vogelstein
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

8.  Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

Authors:  Keishi Yamashita; Sunil Upadhyay; Motonobu Osada; Mohammad O Hoque; Yan Xiao; Masaki Mori; Fumiaki Sato; Stephen J Meltzer; David Sidransky
Journal:  Cancer Cell       Date:  2002-12       Impact factor: 31.743

Review 9.  Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.

Authors:  Tobey J MacDonald; Brian R Rood; Maria R Santi; Gilbert Vezina; Kimberly Bingaman; Philip H Cogen; Roger J Packer
Journal:  Oncologist       Date:  2003

Review 10.  Cancer epigenetics.

Authors:  Richard L Momparler
Journal:  Oncogene       Date:  2003-09-29       Impact factor: 9.867

View more
  38 in total

Review 1.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

2.  Targeting the enhancer of zeste homologue 2 in medulloblastoma.

Authors:  Irina Alimova; Sujatha Venkataraman; Peter Harris; Victor E Marquez; Paul A Northcott; Adrian Dubuc; Michael D Taylor; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

Review 3.  Epigenetics of neurological cancers.

Authors:  Shaun D Fouse; Joseph F Costello
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

4.  Development and characterization of murine models of medulloblastoma extraneural growth in bone.

Authors:  Jessica M Grunda; Dezhi Wang; Gregory A Clines
Journal:  Clin Exp Metastasis       Date:  2013-03-15       Impact factor: 5.150

5.  Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Authors:  Jennifer A Anderton; Janet C Lindsey; Meryl E Lusher; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Neuro Oncol       Date:  2008-07-29       Impact factor: 12.300

6.  Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines.

Authors:  Ina Patties; Jutta Jahns; Guido Hildebrandt; Rolf-Dieter Kortmann; Annegret Glasow
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

Review 7.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

8.  MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.

Authors:  Sujatha Venkataraman; Irina Alimova; Rong Fan; Peter Harris; Nicholas Foreman; Rajeev Vibhakar
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

9.  Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression.

Authors:  Sung-Min Ahn; Kyunghee Byun; Deokhoon Kim; Kiyoung Lee; Jong Shin Yoo; Seung U Kim; Eek-Hoon Jho; Richard J Simpson; Bonghee Lee
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

10.  Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy.

Authors:  Youxin Zhou; Fang Liu; Qinian Xu; Xiuyun Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.